Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven A Narod

Showing results (111-120 of 544) with videos related to

Pageof 55
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 26, 2017
A Comparison of Survival Outcomes in Advanced Serous Ovarian Cancer Patients Treated With Primary Debulking Surgery Versus Neoadjuvant ChemotherapyTaymaa May, Robyn Comeau, Ping Sun, et al.
Hereditary Cancer in Clinical Practice|November 17, 2011
Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from GreeceChrissovaladis Koumpis, Constantine Dimitrakakis, Aris Antsaklis, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 9, 2007
Significance of lymph vessel invasion identified by the endothelial lymphatic marker D2-40 in node negative breast cancerAngel Arnaout-Alkarain, Harriette J Kahn, Steven A Narod, et al.
Cancer|April 25, 2003
Improved survival in women with BRCA-associated ovarian carcinomaIlana Cass, Rae Lynn Baldwin, Taz Varkey, et al.
British Journal of Cancer|November 14, 2018
Denosumab and breast cancer risk in postmenopausal women: a population-based cohort studyVasily Giannakeas, Suzanne M Cadarette, Joann K Ban, et al.
Breast Cancer Research and Treatment|May 6, 2008
Mutations of the MYH gene do not substantially contribute to the risk of breast cancerMario E Beiner, William W Zhang, Shiyu Zhang, et al.
Gynecologic Oncology|May 3, 2005
Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutationsMurray Joseph Casey, Carrie Synder, Chhanda Bewtra, et al.
Cancers|December 16, 2020
CA125 and Ovarian Cancer: A Comprehensive ReviewParsa Charkhchi, Cezary Cybulski, Jacek Gronwald, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 7, 2004
A polymorphic locus in the promoter region of the IGFBP3 gene is related to mammographic breast densityJoe H Lai, Danny Vesprini, William Zhang, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 17, 2005
Increased rates of chromosome breakage in BRCA1 carriers are normalized by oral selenium supplementationElzbieta Kowalska, Steven A Narod, Tomasz Huzarski, et al.
Pageof 55

Showing results (111-120 of 544) with videos related to

Sort By:
Pageof 55
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 26, 2017
A Comparison of Survival Outcomes in Advanced Serous Ovarian Cancer Patients Treated With Primary Debulking Surgery Versus Neoadjuvant ChemotherapyTaymaa May, Robyn Comeau, Ping Sun, et al.
Hereditary Cancer in Clinical Practice|November 17, 2011
Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from GreeceChrissovaladis Koumpis, Constantine Dimitrakakis, Aris Antsaklis, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 9, 2007
Significance of lymph vessel invasion identified by the endothelial lymphatic marker D2-40 in node negative breast cancerAngel Arnaout-Alkarain, Harriette J Kahn, Steven A Narod, et al.
Cancer|April 25, 2003
Improved survival in women with BRCA-associated ovarian carcinomaIlana Cass, Rae Lynn Baldwin, Taz Varkey, et al.
British Journal of Cancer|November 14, 2018
Denosumab and breast cancer risk in postmenopausal women: a population-based cohort studyVasily Giannakeas, Suzanne M Cadarette, Joann K Ban, et al.
Breast Cancer Research and Treatment|May 6, 2008
Mutations of the MYH gene do not substantially contribute to the risk of breast cancerMario E Beiner, William W Zhang, Shiyu Zhang, et al.
Gynecologic Oncology|May 3, 2005
Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutationsMurray Joseph Casey, Carrie Synder, Chhanda Bewtra, et al.
Cancers|December 16, 2020
CA125 and Ovarian Cancer: A Comprehensive ReviewParsa Charkhchi, Cezary Cybulski, Jacek Gronwald, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 7, 2004
A polymorphic locus in the promoter region of the IGFBP3 gene is related to mammographic breast densityJoe H Lai, Danny Vesprini, William Zhang, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 17, 2005
Increased rates of chromosome breakage in BRCA1 carriers are normalized by oral selenium supplementationElzbieta Kowalska, Steven A Narod, Tomasz Huzarski, et al.
Pageof 55